All research
2026-06-26 PubMed

Moringa oleifera neuroprotective mechanisms reviewed, showing potential for Alzheimer's disease therapy

Therapeutic Potential of Moringa oleifera in Alzheimer's Disease: A Review of Neuroprotective Mechanisms.

Background

Alzheimer's disease (AD) is a devastating neurodegenerative disorder marked by progressive cognitive decline, memory loss, and tau hyperphosphorylation. Current pharmacological treatments primarily offer symptomatic relief, failing to halt or reverse the underlying disease progression. This gap necessitates exploring novel therapeutic avenues, including natural compounds. Moringa oleifera (M.O.), a plant rich in diverse phytochemicals, is being investigated for its potential to address the multifaceted pathology of AD through its antioxidant and anti-inflammatory properties.

Study Design

This review systematically analyzed existing literature on Moringa oleifera's neuroprotective effects in Alzheimer's disease models. It synthesized findings from various in vivo and in vitro studies, focusing on the plant's phytochemical composition and their impact on key AD pathologies. The authors explored how Moringa's bioactives, including flavonoids (Quercetin, kaempferol), phenolic acids, alkaloids, and isothiocyanates, modulate oxidative stress, inflammation, and amyloid-beta processing, drawing conclusions on its therapeutic potential based on reported mechanisms.

Results

The review identified multiple neuroprotective mechanisms attributed to Moringa oleifera phytochemicals. These bioactives prevent oxidative neuronal damage by directly scavenging free radicals and potently inhibiting the release of proinflammatory cytokines by blocking the NF-κB pathway. Isothiocyanates, specifically, were reported to activate the Nrf2/ARE system, leading to the upregulation of cytoprotective enzymes and promotion of brain endogenous antioxidant defenses. In in vivo AD models, Moringa extracts demonstrated anti-AchE activity, improving cholinergic transmission. They also reduced levels and enhanced cognitive performance. The proposed modus operandi includes:

Inhibition of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) activity and direct inhibition of peptide aggregation into neurotoxic oligomers. Furthermore, Moringa functions as a modulator of mitochondrial activity, increasing the activity of endogenous antioxidant enzymes like superoxide dismutase (SOD) and catalase, thereby enhancing neuronal energy metabolism while attempting to block apoptosis.

Key Findings

  • Moringa phytochemicals prevent oxidative neuronal damage by scavenging free radicals.
  • Bioactives inhibit proinflammatory cytokine release by blocking the NF-κB pathway.
  • Isothiocyanates activate the Nrf2/ARE system, upregulating cytoprotective enzymes.
  • Moringa extracts show anti-AchE activity, reducing levels and improving cognition in in vivo models.
  • Mechanisms include BACE1 inhibition, direct aggregation inhibition, and mitochondrial modulation.

Why It Matters

This review consolidates evidence suggesting Moringa oleifera could offer a multi-targeted approach for Alzheimer's disease therapy, addressing oxidative stress, inflammation, and amyloid pathology simultaneously. For individuals exploring natural interventions, this highlights a promising candidate, though it's crucial to remember this is a review of preclinical data. Translating these findings into a usable human protocol requires significant further research, including rigorous clinical trials to establish efficacy, safety, and optimal dosing schedules. While not yet a clinical recommendation, it underscores the potential of plant-derived compounds in neurodegenerative disease management and may inform future drug development strategies.


moringa-oleifera alzheimers-disease neuroprotection oxidative-stress inflammation amyloid-beta
Source: pubmed:42358561 · Ingested 2026-06-26 · Digest: gemini-2.5-flash